GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grand Pharmaceutical Group Ltd (HKSE:00512) » Definitions » Gross Margin %

Grand Pharmaceutical Group (HKSE:00512) Gross Margin % : 58.49% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Grand Pharmaceutical Group Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Grand Pharmaceutical Group's Gross Profit for the six months ended in Dec. 2023 was HK$2,656 Mil. Grand Pharmaceutical Group's Revenue for the six months ended in Dec. 2023 was HK$4,540 Mil. Therefore, Grand Pharmaceutical Group's Gross Margin % for the quarter that ended in Dec. 2023 was 58.49%.


The historical rank and industry rank for Grand Pharmaceutical Group's Gross Margin % or its related term are showing as below:

HKSE:00512' s Gross Margin % Range Over the Past 10 Years
Min: 38.23   Med: 57.05   Max: 63.52
Current: 61.96


During the past 13 years, the highest Gross Margin % of Grand Pharmaceutical Group was 63.52%. The lowest was 38.23%. And the median was 57.05%.

HKSE:00512's Gross Margin % is ranked better than
75.45% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.705 vs HKSE:00512: 61.96

Grand Pharmaceutical Group had a gross margin of 58.49% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Grand Pharmaceutical Group was 2.30% per year.


Grand Pharmaceutical Group Gross Margin % Historical Data

The historical data trend for Grand Pharmaceutical Group's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Pharmaceutical Group Gross Margin % Chart

Grand Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.32 63.52 61.03 62.24 61.96

Grand Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.40 62.54 61.88 64.59 58.49

Competitive Comparison of Grand Pharmaceutical Group's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grand Pharmaceutical Group's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Grand Pharmaceutical Group's Gross Margin % falls into.



Grand Pharmaceutical Group Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Grand Pharmaceutical Group's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=6524.1 / 10529.59
=(Revenue - Cost of Goods Sold) / Revenue
=(10529.59 - 4005.524) / 10529.59
=61.96 %

Grand Pharmaceutical Group's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=2655.6 / 4540.104
=(Revenue - Cost of Goods Sold) / Revenue
=(4540.104 - 1884.475) / 4540.104
=58.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Grand Pharmaceutical Group  (HKSE:00512) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Grand Pharmaceutical Group had a gross margin of 58.49% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Grand Pharmaceutical Group Gross Margin % Related Terms

Thank you for viewing the detailed overview of Grand Pharmaceutical Group's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grand Pharmaceutical Group (HKSE:00512) Business Description

Traded in Other Exchanges
Address
99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG
Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from China and also has a presence in America; Europe; Asia other than the PRC and others.

Grand Pharmaceutical Group (HKSE:00512) Headlines

No Headlines